• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sirnaomics Oncology IND Receives Approval from FDA americanpharmaceuticalreview
    August 17, 2018
    Sirnaomics announces the U.S. Food and Drug Administration (FDA) has approved the company's first oncology IND application. The IND approval will allow for the study of the company's lead product candidate, STP705, in patients with advanced cholangiocarci

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service